Enterprise software maker Varonis Systems Inc. (NASDAQ: VRNS) held its initial public offering Friday morning. The company sold 4.8 million shares at an IPO price of $22, which was above the recently raised expected range of $19 to $21, and well above the initial range of $17 to $19. At the IPO price, market value of Varonis is about $524 million.
Morgan Stanley, Barclays, Jefferies and RBC Capital were joint bookrunning managers for the offering and have an option on an additional 720,000 shares. At the IPO price, and including the overallotment, net proceeds from the IPO would be around $106 million. The company said in its filing that it is using the IPO to raise capital and to create a public market for its common stock.
Varonis makes a software platform that large enterprises can use to manage their unstructured data, such as letters, memos and emails — the stuff created by people that is difficult to map and manage. Varonis is the first technology company to hold an IPO in 2014, which has so far been the year of the biotechs.
On Thursday, medical equipment maker Lumenis Ltd. (NASDAQ: LMNS) came public at an IPO price of $12.50, below its expected range of $15 to $17. The Israel-based maker of minimally invasive clinical solutions for surgical, ophthalmic and aesthetic applications saw its share close at $12.15 Thursday, after rising to a high of $13.38 earlier in the day. The shares traded at $12.46 in the late morning on Friday.
But Varonis is blowing the doors off — up more than 77% at $38.84, after hitting an early peak of $39.75.